Project Details
Description
An Open-label, Phase 1/2 Study to Evaluate the Safety and Efficacy of Single-dose PR001A in Infants with Type 2 Gaucher Disease
| Status | Active |
|---|---|
| Effective start/end date | 9/8/20 → 1/1/26 |
Funding
- PREVAIL THERAPEUTICS INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.